Beijing Aosaikang Pharmaceutical (002755) Stock Overview
Beijing Aosaikang Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
002755 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Beijing Aosaikang Pharmaceutical Co., Ltd. Competitors
Shenzhen Hepalink Pharmaceutical Group
Shanghai Shyndec Pharmaceutical
Guangdong Taienkang Pharmaceutical
Nanjing King-Friend Biochemical PharmaceuticalLtd
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.02 |
| 52 Week High | CN¥20.54 |
| 52 Week Low | CN¥9.04 |
| Beta | 0.17 |
| 1 Month Change | 4.28% |
| 3 Month Change | 8.82% |
| 1 Year Change | 89.88% |
| 3 Year Change | 92.93% |
| 5 Year Change | -14.19% |
| Change since IPO | 40.67% |
Recent News & Updates
Recent updates
Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Shares Climb 25% But Its Business Is Yet to Catch Up
Mar 16
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) A Risky Investment?
Mar 05A Look At The Fair Value Of Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755)
Feb 11Some Confidence Is Lacking In Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) P/S
Jan 17Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking
Oct 18Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?
Oct 11Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem
Sep 05Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues
May 21Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?
Apr 29There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump
Mar 13Shareholder Returns
| 002755 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 12.8% | 3.7% | 1.2% |
| 1Y | 89.9% | 23.2% | 23.9% |
Return vs Industry: 002755 exceeded the CN Pharmaceuticals industry which returned 23.2% over the past year.
Return vs Market: 002755 exceeded the CN Market which returned 23.9% over the past year.
Price Volatility
| 002755 volatility | |
|---|---|
| 002755 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 9.8% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 002755 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002755's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 988 | Jingfei Ma | www.ask-pharm.com |
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas.
Beijing Aosaikang Pharmaceutical Co., Ltd. Fundamentals Summary
| 002755 fundamental statistics | |
|---|---|
| Market cap | CN¥16.74b |
| Earnings (TTM) | CN¥183.48m |
| Revenue (TTM) | CN¥1.84b |
Is 002755 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002755 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.84b |
| Cost of Revenue | CN¥340.63m |
| Gross Profit | CN¥1.50b |
| Other Expenses | CN¥1.31b |
| Earnings | CN¥183.48m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 29, 2025
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 81.46% |
| Net Profit Margin | 9.98% |
| Debt/Equity Ratio | 1.5% |
How did 002755 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/07 08:39 |
| End of Day Share Price | 2025/07/07 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Aosaikang Pharmaceutical Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shitong Han | Citic Securities Co., Ltd. |
| Yinhao Tang | Citic Securities Co., Ltd. |
| Song Yang | Tianfeng Securities Brokerage Co., Ltd |